Chase Knickerbocker
Stock Analyst at Craig-Hallum
(1.91)
# 2,836
Out of 4,814 analysts
36
Total ratings
33.33%
Success rate
-6.82%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $23 → $26 | $14.29 | +81.95% | 5 | Mar 19, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $4.13 | +57.38% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $17.09 | +128.20% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.73 | +1,000.41% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $11.60 | +81.11% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $2.26 | +166.08% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $2.57 | +366.93% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $2.75 | +263.64% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $9.05 | +76.89% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $23.96 | +171.34% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $5.10 | +194.12% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $6.69 | +79.37% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $6.99 | +43.06% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $8.06 | +185.54% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.42 | +188.05% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $4.08 | +414.71% | 1 | Mar 13, 2023 |
Eton Pharmaceuticals
Mar 19, 2025
Maintains: Buy
Price Target: $23 → $26
Current: $14.29
Upside: +81.95%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $4.13
Upside: +57.38%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $17.09
Upside: +128.20%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.73
Upside: +1,000.41%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $11.60
Upside: +81.11%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $2.26
Upside: +166.08%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $2.57
Upside: +366.93%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $2.75
Upside: +263.64%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $9.05
Upside: +76.89%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $23.96
Upside: +171.34%
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $5.10
Upside: +194.12%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $6.69
Upside: +79.37%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $6.99
Upside: +43.06%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $8.06
Upside: +185.54%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.42
Upside: +188.05%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $4.08
Upside: +414.71%